Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas

JCO Precis Oncol. 2021 May 20:5:PO.20.00444. doi: 10.1200/PO.20.00444. eCollection 2021.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Benzimidazoles / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Child
  • Child, Preschool
  • Glioma / drug therapy*
  • Humans
  • Infant
  • Pyrazoles / therapeutic use*
  • Receptors, Fibroblast Growth Factor / antagonists & inhibitors*

Substances

  • Benzimidazoles
  • CH5183284
  • Pyrazoles
  • Receptors, Fibroblast Growth Factor